CTRI/2016/05/006976
Completed
未知
A prospective, randomized, double blind, placebo controlled clinical study to evaluate the efficacy and safety of bilberries extract capsules (180mg) in the eye health of human adults.
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Vidya herbs
- Enrollment
- 30
- Status
- Completed
- Last Updated
- 4 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Males \& Females with age 30â??60 year
- •Subjects able to provide informed consent.
- •Patient is willing and able to comply with all trial requirements
- •Subjects is having at least anyone of the following condition\- Eye strain / redness / watering / burning sensation / itching in the eyes / acuity of vision.
Exclusion Criteria
- •Subject has had the crystalline lens removed from the study eye or has had the crystalline lens removed and replaced with an intraocular lens (IOL) implant in the left eye.
- •Subject has been clinically diagnosed with cataracts in the study eye.
- •Subject has had a fluorescence angiogram within the last six months.
- •Pregnant or lactating women
- •Subject has undergone a treatment using photodynamic drugs within the last year.
- •Subject has Type I or II diabetes or is not deemed healthy from Demographic and Health Questionnaire or the comprehensive eye exam.
- •Subject was fit with contact lens within the last 30 days.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 4
Clinical study of Oligocare Forte Plus versus placebo in sub-fertile males.Health Condition 1: N461- OligospermiaCTRI/2020/12/029590Meyer Organics Pvt Ltd300
Completed
Phase 2
A clinical study of Curcuvail�® in in patients with Non-alcoholic Fatty Liver DiseaseHealth Condition 1: K760- Fatty (change of) liver, not elsewhere classifiedCTRI/2021/01/030302K Patel Phyto Extractions Pvt Ltd30
Completed
Phase 2
A clinical study of Dose for your Liver (Dietary Supplement) in patients with Non-alcoholic Fatty Liver DiseaseHealth Condition 1: K760- Fatty (change of) liver, not elsewhere classifiedCTRI/2021/08/035359Eetho Brands Inc30
Unknown
Phase 1
A Clinical study to evaluate safety, tolerability, pharmacokinetics and pharmacodynamics of ZYKR1 in healthy volunteers.CTRI/2018/07/014927Cadila Healthcare Ltd
Completed
Not Applicable
Evaluation of effects of fenugreek extract on body fat mass.Health Condition 1: null- High fat massHealth Condition 2: E663- OverweightCTRI/2013/10/004050Indus Biotech Private Limited Pune24